JPMorgan maintains Overweight rating on Nongfu Spring-H with a target price of HK$55.00

Overview

This is a model update report on Nongfu Spring-H (9633.HK). JPMorgan updated its model to reflect the 2025 full-year balance sheet and cash flow statement, while maintaining its earnings forecasts, Overweight rating, and Dec-26 target price of HK$55.00 unchanged. The core view of the report is that the company holds a leading position in China's non-alcoholic beverage industry, with a balanced product portfolio, strong brand and execution capabilities, and resilience demonstrated in the volatile 2024-2025 environment.

Core views

The report argues that Nongfu Spring's investment case mainly comes from three points: first, the company holds a leading position in China's non-alcoholic beverage sector and has momentum for continued market share gains; second, water, tea beverages, functional beverages, juice, and other products form a relatively balanced product portfolio, and the company has product innovation and differentiation capabilities; third, the company's strong historical operating resilience should help support its valuation multiple in the normalized environment after 2025. JPMorgan forecasts 2025-2028 revenue CAGR of 11% and EPS CAGR of 9%.

Analysis framework

The report uses earnings forecast updates, revenue breakdown by business segment, margin assumptions, cash flow and balance sheet updates, and a relative valuation approach for analysis. The target price is derived using 30x 2027E earnings per share and references the company's historical trading range of about 35x average 12-month forward P/E since April 2021.

Methodology notes

• Valuation methodsTarget P/E method

  30x 2027E P/E

  The Dec-26 target price of HK$55.00 is based on 30x 2027E P/E, which the report believes is supported by the company's leading position, market share gains, product portfolio, and operating resilience.

• Earnings forecastRevenue and EPS CAGR

  2025-2028 revenue CAGR 11%, EPS CAGR 9%

  The report assesses the company's medium-term growth capability through forecasts of revenue, margins, net profit, and EPS from 2025A to 2028E.

• Factor analysisStyle Exposure

  High ranking on quality factor, low ranking on value factor

  The quantitative table shows Quality currently ranks 1, ESGQ 6, and Value 89, reflecting strong market recognition of the company's quality attributes, but indicating that the valuation is not cheap.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

• Nongfu Spring-H (9633.HK)

  Core covered name

  Strengths

  Strong overall capabilities within China's non-alcoholic beverage sub-sector; strategic focus on water and beverage businesses; continued brand investment; relatively balanced product portfolio; good operating resilience and historical execution.

  Weaknesses

  Valuation is not low, with the target price based on a relatively high 30x 2027E P/E; 2026E adjusted EPS growth is only 3.7%, implying relatively moderate short-term earnings growth.

  Comparison

  The report notes that the company's average 12-month forward P/E since April 2021 has been about 35x; the 30x target valuation is below the historical average but still reflects a premium for a high-quality consumer leader.

  Risks

  Industry competition and price wars, input cost inflation, failed new product launches, reputational risk.

• Hang Seng Index

  Relative performance benchmark

  Strengths

  The report's price performance chart uses rebased HSI as the comparison benchmark.

  Weaknesses

  No fundamental analysis of the Hang Seng Index is provided.

  Comparison

  The table shows absolute return of 32.9% and relative return of 10.6% over the past 12 months.

  Risks

  Overall Hong Kong market risk appetite, as well as regional and macro factors, may affect valuation performance.

Key data

• Current priceHK$48.70As of April 20, 2026
• Target priceHK$55.00Dec-26 target price
• Implied upsideabout 12.9%Calculated based on the HK$55.00 target price and HK$48.70 current price
• RatingOverweightThe report maintains the previous rating
• 2025A revenueRMB 52,553 mnFinancial forecast table
• 2026E revenueRMB 59,199 mnYoY growth of 12.6%
• 2027E revenueRMB 65,499 mnYoY growth of 10.6%
• 2028E revenueRMB 71,357 mnYoY growth of 8.9%
• 2025-2028E revenue CAGR11%Disclosed in the main body of the report
• 2025-2028E EPS CAGR9%Disclosed in the main body of the report
• 2027E adjusted P/E25.1xFinancial forecast table
• Historical average 12-month forward P/Eabout 35xSince April 2021, excluding periods of extremely high P/E

Impact & implications

The report's direct impact on the stock is moderately positive but with limited marginal change, as this is a model update rather than a rating or earnings forecast upgrade. Maintaining the Overweight rating and HK$55.00 target price indicates that the analyst still recognizes the company's medium- to long-term competitiveness, brand strength, and operating resilience; however, the current share price implies only about 12.9% upside, while the company's valuation already reflects a substantial quality premium. Going forward, it will be necessary to monitor whether revenue growth, margin recovery, new product performance, and the competitive environment can support the 30x target P/E.

Risks

• Intensifying industry competition and price wars may pressure revenue growth and margins.
• Raw material or input cost inflation may erode gross margin.
• New product launches falling short of expectations may weaken growth momentum.
• Reputational risk may affect brand equity and consumer demand.
• If the market does not assign a 30x 2027E P/E, there is valuation risk to achieving the target price.

What to watch

• Whether 2026E revenue can reach RMB 59,199 mn and 12.6% YoY growth.
• Whether gross margin can gradually recover from 58.3% in 2026E to 59.0% in 2027E and 2028E.
• Whether segment growth in tea beverages, packaged drinking water, functional beverages, and juice can continue.
• Whether 2027E EPS can reach RMB 1.69 and support the 30x target P/E.
• Industry price competition, marketing spending, and changes in raw material costs.
• The company's 12-month forward P/E relative to the historical average of 35x and its position within the 26x, 30x, 40x, and 44x valuation bands.